Consistently, in a recent randomized, controlled clinical study, Guo et al. demonstrated that NLRP3 inflammasome activation is significantly increased in patients with MASLD, but that this activation can be strongly repressed by anthocyanins (provided here by blueberry extract, Vaccinium myrtillus L41). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.